MedPath

ow FODMAPs diet in patients with IBS-D

Not Applicable
Conditions
Irritable bowel syndrome.
Irritable bowel syndrome with diarrhoea
Registration Number
IRCT2017093033308N1
Lead Sponsor
Vice Chancellor for research; Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
110
Inclusion Criteria

. Inclusion criteria for participants' enrollment were IBS with diarrhea subtype (Bristol Stool Form Scale = 5) and age 20-60 years old. Exclusion criteria were having a confounder medical condition such as celiac disease, inflammatory bowel disease (IBD) or presence of cardiovascular, liver, kidney, neurologic diseases, diabetes and thyroid disorders, consumption of ?-3 FAs and other nutritional supplements in the last 3 months, pregnancy in during the study. The use of effective drugs against IBS such as drugs affecting GI motility was not allowed, but antidepressants drugs were allowed on a stable dose for the last 3 months before inclusion.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gastrointestinal symptoms. Timepoint: 3 weeks. Method of measurement: questionnaire.;Bowel habit status. Timepoint: 6 weeks. Method of measurement: questionnaire.
Secondary Outcome Measures
NameTimeMethod
Quality of life. Timepoint: 6 weeks. Method of measurement: questionnaire.
© Copyright 2025. All Rights Reserved by MedPath